Abstract
Gold drugs are still amongst the most efficacious for the treatment of rheumatoid arthritis. Their mechanism of action, as well as the molecular basis of their side-effects, remain poorly understood. Current theories are reviewed, including recent potential breakthroughs. The interaction of gold(III) with peptides and proteins and its immunochemical implications are discussed.
Article PDF
References
P. J. Sadler,Adv. Inorg. Chem., 1991,36, 1
G. Sava, in ‘Metal Compounds in Cancer Therapy’, ed. S.P. Fricker, Chapman and Hall, London, 1994, p.65
G.D. Champion, G.G. Graham and J.B. Ziegler,Baillieres Clin. Rbeumatol., 1990,4, 491
L. Treagan,Metal Ions in Biol. Syst., 1983,16, 27
I. Schröter and J. Strähle,Chem. Ber., 1991,124, 2161
J.L. Abruzzo and R.J. DeHoratius,Am. J Trop. Med. Hyg., 1969,18, 506
R.E. Thomas and R.A. Papandrea,Med. J Austral., 1993,158, 720
T. Okada, B.K. Patterson, S.-Q. Ye and M.E. Gurney,Virology, 1993,192, 631
R.C Elder, Z. Zhao, Y Zhang, J.G. Dorsey, E.V. Hess and K.J. Tepperman,J Rheumatol., 1993,20, 268
Y.F. Zhang, E.V. Hess, K.G. Pryhuber, J.G. Dorsey, K. Tepperman and R.C Elder,Inorg. Chim. Acta, 1995,229, 271
G.W. Rafter, J. Inorg.Biocbem., 1990,38, 261
C.W. Mahoney, C.E. Hensey, and A. Azzi,Biochem. Pharmacol., 1989,38, 3383
T. Herlin, K. Fogh, N.O. Christiansen and K. Kragballe,Agents and Actions, 1989,28, 121
P. E. McGowan, J.M. Campbell, J. Reglinski and W.E. Smith,Inorg. Chim. Acta, 1993,210, 1
M.L. Handel, A. deFazio, C.K.W Watts, R.O. Day and R.L. Sutherland,Mol. Pharmacol., 1991,40, 613
R. Rudkowski, G.G. Graham, G.D. Champion and J.B. Ziegler,Biochem. Pharmacol., 1990,39, 1687
G.G. Graham, J.R. Bales, M.C Groorveld and P.J. Sadler,J. Inorg. Biochem., 1985,25, 163
G.G. Graham, T.M. Haavisto, P.J. McNaught, C.D. Browne, and G.D. Champion,J. Rheumatol., 1982,9, 527
G. Salmeron and P.E. Lipsky,J. Rbeumatol. Suppl., 1982,8, 25
P.E. Lipsky and M. Ziff,J. Clin. Invest., 1977,59, 455
P. Romagnoli, G.A. Spinas and F. Sinigaglia,J. Clin. Lnvest, 1992,89, 254
F. Sinigaglia,J. Invest. Dermatol., 1994,102, 398
P. Griem, K. Takahashi, H. Kalbacher and E. Gleichmann,J. Immunol., 1995,155, 1575
P. Griem and E. Gleichmann,Curr. Opin. Immunol., 1995,7, 831
P.J. Sadler,Gold. Bull., 1976,9, 110
26 D.H. Brown and W.E. Smith,Chem. Soc. Rev., 1980,9, 217
P.J. Sadler and R.E. Sue,Metal-Based Drugs, 1994,1, 107
C.F. Shaw III,Inorg. Perspect. BioI. Med., 1979,2, 287
C.F. Shaw III,Comments Inorg. Chem., 1989,8, 233
A.J. Lewis and D.T. Walz,Prog. Med. Chem., 1982,19, 1
C.F. Shaw III, A.A. Isab, M.T. Coffer and C. Mirabelli,Biochem. Pharmacol., 1990,40, 1227
O.M. Ni Dhubhghaill, P.J. Sadler and A. Tucker,J. Am. Chem. Soc., 1992,114, 1118
J. Christodoulou, P.J. Sadler and A. Tucker,Eur. J. Biochem., 1994,225, 363
J.R. Roberts, J. Xiao, B. Schliesman, D.J. Parsons and C.F. Shaw III,Inorg. Chem., 1996,35, 424
J. Christodoulou, P.J. Sadler and A. Tucker,FEBS Letters, 1995,376, 1
D. Schuhmann, M. Kubickamuranyi, J. Mirtschewa, J. Gunther, P. Kind and E. Gleichmann,J. Immunol., 1990,145, 2132
J. Verwilghen, G.H. Kingsley, L. Gambling and G.S. Panayi,Arthritis Rheum., 1992,35, 1413
P. Griem, K. Panrhel, H. Kalbacher and E. Gleichmann,Eur J Immunol., 1996,26, 279
B. Beverly and D. Couri,Fed. Proc., 1987,46, 854
C.F. Shaw III, S. Schraa, E. Gleichmann, Y.P. Grover, L. Dunemann and A. Jagarlamudi,Metal Based Drugs, 1994,1, 351
T.L. Blundell and L.N. Johnson, ‘Protein Crystallography’, Academic Press, New York, 1976
P.L. Witkiewicz and C.F. Shaw III,Chem. Commun., 1981, 1111
D.H. Brown and W.E. Smith,Am. Chem. Soc. Symp. Ser., 1983,209, 401
W.E. Smith and J. Reglinski,Perspec. Bioinorg. Chem., 1991,1, 183
C.F. Shaw III, M.P. Cancro, P.L. Witkiewicz and J.E. Eldridge,Inorg. Chem., 1980,19, 3198
E. Bordignon, L. Cattalini, G. Natile and A. Scatturin,Chem. Commun., 1973, 878
G. Natile, E. Bordignon and L. Catralini,Inorg. Chem., 1976,15, 246
A.A. Isab and P.J. Sadler,Biochim. Biophys. Acta, 1977,492, 322
M. Wienken, B. Lippert, E. Zangrando and L. Randaccio,Inorg. Chem., 1992,31, 1983
S.L. Best., TK. Chattopadhyay, M.I. Djuran, R.A. Palmer, P.J. Sadler, I. Sóvágó and K. Varnagy, in preparation
S.L. Best, M.I. Djuran and P.J. Sadler, In preparation
R.J. Sundberg and R.B. Martin,Chem. Rev., 1974,74, 471
R.J. Sundberg and G. Gupta,Bioinorg. Chem., 1973,3, 39
W.J. Eilbeck and M.S. West,J. Chem. Soc., Dalton Trans., 1976, 274
C.A. Evans, D.L. Rabenstein, G. Geier and I.W. Erni,J. Am. Chem. Soc., 1977,99, 8106
T.P. Pitner, E.W. Wilson and R.B. Martin,Inorg. Chem., 1972,11, 738
Author information
Authors and Affiliations
Additional information
Sabine Best has recently completed her PhD at Birkbeck College, University of London on the biological chemistry of gold, and is currently a research fellow in the School of Biological Sciences at Queen Mary and Westfield College, London. Peter Sadler has just taken up the Crum Brown Chair of Chemistry at the University of Edinburgh after 23 years at Birkbeck College. His major research interests lie in the chemistry of metals in medicine.
Rights and permissions
This article is published under an open access license. Please check the 'Copyright Information' section either on this page or in the PDF for details of this license and what re-use is permitted. If your intended use exceeds what is permitted by the license or if you are unable to locate the licence and re-use information, please contact the Rights and Permissions team.
About this article
Cite this article
Best, S.L., Sadler, P.J. Gold drugs: Mechanism of action and toxicity. Gold Bull 29, 87–93 (1996). https://doi.org/10.1007/BF03214741
Issue Date:
DOI: https://doi.org/10.1007/BF03214741